Q&A: Is There an Infection Preventionist in the House?
Infection preventionists and their skills will be in high demand in coming years in non-healthcare settings.
Jason Tetro thinks that the demand for infection prevention expertise will grow well beyond the confines of healthcare settings. Tetro, author of the The Germ Code and The Germ Files, and host of the popular podcast series, The Super Awesome Science Show, talks to Infection Control Today® about how private industry and public institutions will need to lean on infection preventionists. Tetro predicts that we’ll see infection preventionists in areas such as food processing, travel conveyances, and even theater or sporting events. And, if not infection preventionists themselves, then people who’ve been trained by infection preventionists. Infection prevention will become as much a part of workplace—and any other place where people gather—as CPR is now. There will at least be someone in the crowd who knows the rudimentary IP skills, and who will also know how to get a certified infection preventionist on the scene pronto.
Healing With Algorithms: AI's Impact on Epidemiology and Infection Control
April 2nd 2024Media in the US presents AI as both beneficial and risky. Positive coverage shows AI's potential through virtual assistants like Siri, while cautionary tales warn of misuse like misinformation and deepfakes. How does all this work in health care?
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
